• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MGZ
Click for more information
0.00% 2.0¢

MEDIGARD LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MGZMarketing - Product Evaluation USAPRICE SENSITIVE12/11/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE26/10/09
MGZAnnual Report to shareholders20/10/09
MGZFull Year Statutory Accounts30/09/09
MGZPreliminary Final ReportPRICE SENSITIVE31/08/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/07/09
MGZLetter to ShareholdersPRICE SENSITIVE07/07/09
MGZExpiry of Options19/06/09
MGZGrant of US PatentPRICE SENSITIVE10/06/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/04/09
MGZChange of Director's Interest Notice22/04/09
MGZChange of Director's Interest Notice22/04/09
MGZChange of Director's Interest Notice22/04/09
MGZChange of Director's Interest Notice22/04/09
MGZChange of Director's Interest Notice09/04/09
MGZChange of Director's Interest Notice09/04/09
MGZChange of Director's Interest Notice09/04/09
MGZChange of Director's Interest Notice09/04/09
MGZAppendix 3B02/04/09
MGZBonus IssuePRICE SENSITIVE02/04/09
MGZCompletion of Share Purchase Plan02/04/09
MGZChange of Director's Interest Notice31/03/09
MGZLetter to Shareholders20/03/09
MGZExtension of Share Purchase Plan13/03/09
MGZMarketing - Product Evaluation USA11/03/09
MGZShareholder Presentation04/03/09
MGZLetter to Shareholders02/03/09
MGZHalf Yearly Report and AccountsPRICE SENSITIVE27/02/09
MGZClarification of Share Purchase Plan and Loyalty Options23/02/09
MGZShare Purchase PlanPRICE SENSITIVE11/02/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/01/09
MGZChange of Director's Interest Notice22/01/09
MGZAppendix 3B22/01/09
MGZFDA Approval for Blood Collection DevicePRICE SENSITIVE19/01/09
MGZMarketing - Product Evaluation USA
12/11/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
26/10/09PRICE SENSITIVE
MGZAnnual Report to shareholders
20/10/09
MGZFull Year Statutory Accounts
30/09/09
MGZPreliminary Final Report
31/08/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/07/09PRICE SENSITIVE
MGZLetter to Shareholders
07/07/09PRICE SENSITIVE
MGZExpiry of Options
19/06/09
MGZGrant of US Patent
10/06/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/04/09PRICE SENSITIVE
MGZChange of Director's Interest Notice
22/04/09
MGZChange of Director's Interest Notice
22/04/09
MGZChange of Director's Interest Notice
22/04/09
MGZChange of Director's Interest Notice
22/04/09
MGZChange of Director's Interest Notice
09/04/09
MGZChange of Director's Interest Notice
09/04/09
MGZChange of Director's Interest Notice
09/04/09
MGZChange of Director's Interest Notice
09/04/09
MGZAppendix 3B
02/04/09
MGZBonus Issue
02/04/09PRICE SENSITIVE
MGZCompletion of Share Purchase Plan
02/04/09
MGZChange of Director's Interest Notice
31/03/09
MGZLetter to Shareholders
20/03/09
MGZExtension of Share Purchase Plan
13/03/09
MGZMarketing - Product Evaluation USA
11/03/09
MGZShareholder Presentation
04/03/09
MGZLetter to Shareholders
02/03/09
MGZHalf Yearly Report and Accounts
27/02/09PRICE SENSITIVE
MGZClarification of Share Purchase Plan and Loyalty Options
23/02/09
MGZShare Purchase Plan
11/02/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
29/01/09PRICE SENSITIVE
MGZChange of Director's Interest Notice
22/01/09
MGZAppendix 3B
22/01/09
MGZFDA Approval for Blood Collection Device
19/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising! Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Global Lithium up 13% as it joins the ranks of battery metal players pivoting to gold Global Lithium (ASX:GL1) has joined the ranks of lithium miners turning to other metals as the great lithium rerate makes uneconomic another project. On Wednesday, the company acquired Octava Minerals’ (ASX:OCT) Talga Project, prospective for gold and base metals. That play is loc...
Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come On Chris Judd’s Talk Ya Book today, the AFL legend sat down with Orthocell Limited (ASX:OCC) chairman John Van Der Wielen to talk about the @overnight success” of the ASX-listed biotech company and its bright future.@We wanted to start at the top and get a st...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.